Lack of association between adiponectin levels and atherosclerosis in mice.
Lack of association between adiponectin levels and atherosclerosis in mice.
复制标题
DOI:
10.1161/atvbaha.109.195826
复制
发表时间:
2010-06
期刊:
影响因子:
--
通讯作者:
Scherer PE
中科院分区:
文献类型:
--
作者:
Nawrocki AR;Hofmann SM;Teupser D;Basford JE;Durand JL;Jelicks LA;Woo CW;Kuriakose G;Factor SM;Tanowitz HB;Hui DY;Tabas I;Scherer PE
Adiponectin is an adipocyte-derived, secreted protein that is implicated in the protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to PPARγ agonists. Adiponectin has been associated with anti-inflammatory and anti-atherogenic properties, however, the direct involvement of adiponectin on the atherogenic process has not been studied. We crossed adiponectin knockout mice (Adn−/−) or mice with chronically elevated adiponectin levels (AdnTg) into the low-density lipoprotein receptor null (Ldlr−/−) and the apoliprotein E null (Apoe−/−) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain- and loss-of-function studies in mice may suggests lack of causation for adiponectin in inhibiting the build up of atherosclerotic lesions. These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models.